.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Citi
US Department of Justice
QuintilesIMS
Harvard Business School
UBS
Cerilliant
Argus Health
Healthtrust
US Army

Generated: January 20, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Patent: PCT/US87/01612

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Pf Prism CvZMAXazithromycinFOR SUSPENSION, EXTENDED RELEASE;ORAL050797-001Jun 10, 2005RXYesYes➤ Subscribe➤ SubscribeY
PfizerZITHROMAXazithromycinFOR SUSPENSION;ORAL050693-001Sep 28, 1994RXYesYes➤ Subscribe➤ SubscribeY
PfizerZITHROMAXazithromycinFOR SUSPENSION;ORAL050710-001Oct 19, 1995ABRXYesNo➤ Subscribe➤ SubscribeY
PfizerZITHROMAXazithromycinFOR SUSPENSION;ORAL050710-002Oct 19, 1995ABRXYesYes➤ Subscribe➤ SubscribeY
PfizerZITHROMAXazithromycinINJECTABLE;INJECTION050733-001Jan 30, 1997APRXYesYes➤ Subscribe➤ SubscribeY
PfizerZITHROMAXazithromycinTABLET;ORAL050711-001Jul 18, 1996ABRXYesNo➤ Subscribe➤ SubscribeY
PfizerZITHROMAXazithromycinTABLET;ORAL050730-001Jun 12, 1996ABRXYesYes➤ Subscribe➤ SubscribeY
PfizerZITHROMAXazithromycinTABLET;ORAL050784-001May 24, 2002ABRXYesNo➤ Subscribe➤ SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist